Statement on imaging and pulmonary hypertension from the Pulmonary Vascular Research Institute (PVRI)
David G. Kiely(Royal Hallamshire Hospital), Andrew J. Swift(Glasgow Centre for Population Health), Paul M. Hassoun(Johns Hopkins University), Pei‐Ni Jone(Northwestern University), Stephen J. Wort(Royal Brompton Hospital), Shahin Moledina(Great Ormond Street Hospital), Mark L. Schiebler(University of Wisconsin–Madison), D. Dunbar Ivy(University of Colorado Denver), David L. Levin(University of California San Diego), Anton Vonk Noordegraaf(Amsterdam University Medical Centers), Jumaa Bwika(Aga Khan University Nairobi), Michal Schäfer(Children's Hospital Colorado), Jim Lordan(Freeman Hospital), Angela Lungu(Technical University of Cluj-Napoca), Merryn H. Tawhai(University of Auckland), Steven M. Kawut(Hospital of the University of Pennsylvania), Edwin J.R. van Beek(University of Edinburgh), Jeremy A. Mazurek(University of Pennsylvania), Horst Olschewski(Sigmund Freud Privatuniversität Wien), Jens Vogel‐Claussen(Medizinische Hochschule Hannover), Lan Zhao(Fujian Medical University), Andrew J. Peacock(Pulmonary Vascular Research Institute), Rebecca Vandepool(University of Arizona), Nicholas Screaton(Papworth Hospital), Jim M. Wild(Insigneo), G. D. Puri(Post Graduate Institute of Medical Education and Research), Farbod N. Rahaghi(Brigham and Women's Hospital)
Cited by 145
Related Papers
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
|European Heart Journal|2022|3.6k
Inhaled Iloprost for Severe Pulmonary Hypertension
|New England Journal of Medicine|2002|1.8k
Pediatric Pulmonary Hypertension
|Circulation|2015|1.1k
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial
|The Lancet|2013|942
Pulmonary hypertension in chronic lung disease and hypoxia
|European Respiratory Journal|2018|777